The Latest Breaking News from Amgen

The Dow Jones Industrial Average fell Tuesday, adding to Monday's stock market plunge. Zoom Video stock dived on earnings.

The biotech industry is expected to see solid growth in the long term due to rising healthcare spending, breakthrough developments, and an aging population. Given the industry’s solid growth prospects and non-cyclical nature, it could be wise to invest in fundamentally strong biotech stocks Gilead Sciences (GILD), Biogen (BIIB), Jazz…

Gainers ChemoCentryx, Inc. (NASDAQ: CCXI) surged 109.2% to settle at $50.43 on Thursday after the company, and Amgen, announced an agreement under which Amgen will acquire the company for $52 per share in cash.

U.S. stocks closed mixed on Thursday following the release of weekly jobless claims data. Here is the list of some big stocks moving higher in the previous session.

The indexes were quiet before the July jobs report tests the Fed's soft landing. Tesla shareholders OK'd a 3-for-1 stock split.

Someone with a lot of money to spend has taken a bearish stance on Amgen (NASDAQ:AMGN). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

Amgen narrowed its outlook for 2022 sales after its second-quarter beat. But Amgen stock fell just a fraction on Friday.

U.S. stocks traded mixed toward the end of trading, with the Dow Jones dropping around 75 points on Thursday

The Nasdaq composite is showing minor strength, higher by less than 0.1%.